Childress Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Childress Capital Advisors's LLY Position: Q1 2026 in Review
Childress Capital Advisors reduced its Eli Lilly (LLY) stake by 26% in Q1 2026, selling an estimated $1.06M and leaving 3,044 shares worth $2.8M. The position accounts for 0.5% of the portfolio, ranked #35.
Childress Capital Advisors first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. The position peaked at $4.39M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Childress Capital Advisors held 3,044 shares of Eli Lilly worth $2.8M as of Q1 2026.
- Childress Capital Advisors sold 1,043 Eli Lilly shares in Q1 2026, an estimated $1.06M.
- Eli Lilly made up 0.5% of Childress Capital Advisors's portfolio in Q1 2026, its #35 holding.
- Childress Capital Advisors first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
- Childress Capital Advisors's Eli Lilly position peaked at $4.39M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Childress Capital Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.